Qu Shuping, Shi Qiuyuan, Xu Jing, Yi Wanwan, Fan Hengwei
Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
Department of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Evol Bioinform Online. 2020 May 18;16:1176934320920562. doi: 10.1177/1176934320920562. eCollection 2020.
This study was aimed at revealing the dynamic regulation of mRNAs, long noncoding RNAs (lncRNAs), and microRNAs (miRNAs) in hepatocellular carcinoma (HCC) and to identify HCC biomarkers capable of predicting prognosis. Differentially expressed mRNAs (DEmRNAs), lncRNAs, and miRNAs were acquired by comparing expression profiles of HCC with normal samples, using an expression data set from The Cancer Genome Atlas. Altered biological functions and pathways in HCC were analyzed by subjecting DEmRNAs to Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis. Gene modules significantly associated with disease status were identified by weighted gene coexpression network analysis. An lncRNA-mRNA and an miRNA-mRNA coexpression network were constructed for genes in disease-related modules, followed by the identification of prognostic biomarkers using Kaplan-Meier survival analysis. Differential expression and association with the prognosis of 4 miRNAs were verified in independent data sets. A total of 1220 differentially expressed genes were identified between HCC and normal samples. Differentially expressed mRNAs were significantly enriched in functions and pathways related to "plasma membrane structure," "sensory perception," "metabolism," and "cell proliferation." Two disease-associated gene modules were identified. Among genes in lncRNA-mRNA and miRNA-mRNA coexpression networks, 9 DEmRNAs and 7 DEmiRNAs were identified to be potential prognostic biomarkers. MIMAT0000102, MIMAT0003882, and MIMAT0004677 were successfully validated in independent data sets. Our results may advance our understanding of molecular mechanisms underlying HCC. The biomarkers may contribute to diagnosis in future clinical practice.
本研究旨在揭示肝细胞癌(HCC)中mRNA、长链非编码RNA(lncRNA)和微小RNA(miRNA)的动态调控,并鉴定能够预测预后的HCC生物标志物。通过使用来自癌症基因组图谱的表达数据集,比较HCC与正常样本的表达谱,获取差异表达的mRNA(DEmRNA)、lncRNA和miRNA。通过对DEmRNA进行基因本体论和京都基因与基因组百科全书分析,分析HCC中改变的生物学功能和通路。通过加权基因共表达网络分析鉴定与疾病状态显著相关的基因模块。为疾病相关模块中的基因构建lncRNA-mRNA和miRNA-mRNA共表达网络,随后使用Kaplan-Meier生存分析鉴定预后生物标志物。在独立数据集中验证了4种miRNA的差异表达及其与预后的相关性。在HCC与正常样本之间共鉴定出1220个差异表达基因。差异表达的mRNA在与“质膜结构”、“感官知觉”、“代谢”和“细胞增殖”相关的功能和通路中显著富集。鉴定出两个与疾病相关的基因模块。在lncRNA-mRNA和miRNA-mRNA共表达网络中的基因中,9个DEmRNA和7个DEmiRNA被鉴定为潜在的预后生物标志物。MIMAT0000102、MIMAT0003882和MIMAT0004677在独立数据集中成功得到验证。我们的结果可能会加深我们对HCC潜在分子机制的理解。这些生物标志物可能有助于未来临床实践中的诊断。